

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 7.72825614 |
| 2 | central nervous system myelination (GO:0022010) | 7.72825614 |
| 3 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.86571407 |
| 4 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 6.68135736 |
| 5 | ATP synthesis coupled proton transport (GO:0015986) | 6.68135736 |
| 6 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 6.49459421 |
| 7 | protein neddylation (GO:0045116) | 5.62490926 |
| 8 | respiratory electron transport chain (GO:0022904) | 5.55928648 |
| 9 | fatty acid elongation (GO:0030497) | 5.52187214 |
| 10 | electron transport chain (GO:0022900) | 5.43844797 |
| 11 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 5.31376419 |
| 12 | chaperone-mediated protein transport (GO:0072321) | 5.07457641 |
| 13 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.94478649 |
| 14 | protein complex biogenesis (GO:0070271) | 4.22762458 |
| 15 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.19497094 |
| 16 | NADH dehydrogenase complex assembly (GO:0010257) | 4.19497094 |
| 17 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.19497094 |
| 18 | positive regulation of TOR signaling (GO:0032008) | 3.95699468 |
| 19 | myelination (GO:0042552) | 3.95282324 |
| 20 | ensheathment of neurons (GO:0007272) | 3.93896632 |
| 21 | axon ensheathment (GO:0008366) | 3.93896632 |
| 22 | substantia nigra development (GO:0021762) | 3.91838914 |
| 23 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.72647519 |
| 24 | hydrogen ion transmembrane transport (GO:1902600) | 3.59355985 |
| 25 | GPI anchor biosynthetic process (GO:0006506) | 3.57572720 |
| 26 | cholesterol biosynthetic process (GO:0006695) | 3.57102373 |
| 27 | negative regulation of protein localization to cell surface (GO:2000009) | 3.51436583 |
| 28 | ribosomal small subunit biogenesis (GO:0042274) | 3.43268845 |
| 29 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.42915408 |
| 30 | L-phenylalanine metabolic process (GO:0006558) | 3.42915408 |
| 31 | heme biosynthetic process (GO:0006783) | 3.41116676 |
| 32 | translational elongation (GO:0006414) | 3.38954902 |
| 33 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.37650550 |
| 34 | mannosylation (GO:0097502) | 3.36603966 |
| 35 | proton transport (GO:0015992) | 3.35238002 |
| 36 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.33645504 |
| 37 | negative regulation of neurotransmitter transport (GO:0051589) | 3.30311292 |
| 38 | ATP biosynthetic process (GO:0006754) | 3.28422371 |
| 39 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.28117412 |
| 40 | GTP biosynthetic process (GO:0006183) | 3.27050057 |
| 41 | GDP-mannose metabolic process (GO:0019673) | 3.26486702 |
| 42 | hydrogen transport (GO:0006818) | 3.26050861 |
| 43 | regulation of cell proliferation involved in kidney development (GO:1901722) | 3.24053357 |
| 44 | regulation of collateral sprouting (GO:0048670) | 3.22984741 |
| 45 | heme metabolic process (GO:0042168) | 3.22696943 |
| 46 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.21631257 |
| 47 | heart process (GO:0003015) | 3.14655622 |
| 48 | heart contraction (GO:0060047) | 3.14655622 |
| 49 | sterol biosynthetic process (GO:0016126) | 3.14646833 |
| 50 | GPI anchor metabolic process (GO:0006505) | 3.14096015 |
| 51 | amyloid precursor protein metabolic process (GO:0042982) | 3.13302098 |
| 52 | oligodendrocyte differentiation (GO:0048709) | 3.13134056 |
| 53 | regulation of mitochondrial translation (GO:0070129) | 3.13030738 |
| 54 | presynaptic membrane organization (GO:0097090) | 3.11799582 |
| 55 | tetrapyrrole biosynthetic process (GO:0033014) | 3.11671556 |
| 56 | regulation of oxidative phosphorylation (GO:0002082) | 3.10129095 |
| 57 | L-phenylalanine catabolic process (GO:0006559) | 3.09498929 |
| 58 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.09498929 |
| 59 | cotranslational protein targeting to membrane (GO:0006613) | 3.08296422 |
| 60 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.07647344 |
| 61 | isoprenoid biosynthetic process (GO:0008299) | 3.07157943 |
| 62 | * establishment of protein localization to mitochondrion (GO:0072655) | 3.03158824 |
| 63 | viral life cycle (GO:0019058) | 3.01279172 |
| 64 | oxidative phosphorylation (GO:0006119) | 2.99920417 |
| 65 | presynaptic membrane assembly (GO:0097105) | 2.98627465 |
| 66 | protein targeting to ER (GO:0045047) | 2.97639989 |
| 67 | viral transcription (GO:0019083) | 2.97478615 |
| 68 | proteasome assembly (GO:0043248) | 2.96743532 |
| 69 | response to redox state (GO:0051775) | 2.96108134 |
| 70 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.92482276 |
| 71 | protein localization to endoplasmic reticulum (GO:0070972) | 2.92285980 |
| 72 | NADH metabolic process (GO:0006734) | 2.92209814 |
| 73 | respiratory chain complex IV assembly (GO:0008535) | 2.91873448 |
| 74 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.91568972 |
| 75 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.90912443 |
| 76 | regulation of catecholamine metabolic process (GO:0042069) | 2.90496146 |
| 77 | regulation of dopamine metabolic process (GO:0042053) | 2.90496146 |
| 78 | nucleotide transmembrane transport (GO:1901679) | 2.89108811 |
| 79 | * mitochondrial transport (GO:0006839) | 2.88239814 |
| 80 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.86431962 |
| 81 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.86431962 |
| 82 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.86203238 |
| 83 | neural nucleus development (GO:0048857) | 2.84572651 |
| 84 | * protein localization to mitochondrion (GO:0070585) | 2.83387869 |
| 85 | neuron cell-cell adhesion (GO:0007158) | 2.80767211 |
| 86 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.80492235 |
| 87 | signal peptide processing (GO:0006465) | 2.77958681 |
| 88 | cellular protein complex disassembly (GO:0043624) | 2.76565722 |
| 89 | amyloid precursor protein catabolic process (GO:0042987) | 2.76010466 |
| 90 | translational termination (GO:0006415) | 2.75854595 |
| 91 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.75602271 |
| 92 | glutathione derivative biosynthetic process (GO:1901687) | 2.73916945 |
| 93 | glutathione derivative metabolic process (GO:1901685) | 2.73916945 |
| 94 | regulation of skeletal muscle contraction (GO:0014819) | 2.73395081 |
| 95 | cellular component biogenesis (GO:0044085) | 2.72729998 |
| 96 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.71632149 |
| 97 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.69491567 |
| 98 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.69488177 |
| 99 | myelin maintenance (GO:0043217) | 2.69153379 |
| 100 | protein maturation by protein folding (GO:0022417) | 2.68559171 |
| 101 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.66721939 |
| 102 | neurotransmitter uptake (GO:0001504) | 2.66275367 |
| 103 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.65284489 |
| 104 | glycerophospholipid catabolic process (GO:0046475) | 2.63201983 |
| 105 | phagosome maturation (GO:0090382) | 2.62697778 |
| 106 | neuronal action potential propagation (GO:0019227) | 2.62352118 |
| 107 | viral protein processing (GO:0019082) | 2.62341279 |
| 108 | * negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.61294187 |
| 109 | inner mitochondrial membrane organization (GO:0007007) | 2.60503828 |
| 110 | establishment of mitochondrion localization (GO:0051654) | 2.59756785 |
| 111 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.58684808 |
| 112 | termination of RNA polymerase III transcription (GO:0006386) | 2.58684808 |
| 113 | cytochrome complex assembly (GO:0017004) | 2.58090718 |
| 114 | protein insertion into membrane (GO:0051205) | 2.57268191 |
| 115 | DNA deamination (GO:0045006) | 2.56992443 |
| 116 | peptidyl-cysteine modification (GO:0018198) | 2.55590249 |
| 117 | response to methylmercury (GO:0051597) | 2.55502478 |
| 118 | * mitochondrion morphogenesis (GO:0070584) | 2.55335456 |
| 119 | translation (GO:0006412) | 2.55233508 |
| 120 | C-terminal protein lipidation (GO:0006501) | 2.55221110 |
| 121 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.54374177 |
| 122 | muscle filament sliding (GO:0030049) | 2.53165781 |
| 123 | actin-myosin filament sliding (GO:0033275) | 2.53165781 |
| 124 | porphyrin-containing compound metabolic process (GO:0006778) | 2.52690982 |
| 125 | dopamine biosynthetic process (GO:0042416) | 2.52377082 |
| 126 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.52013709 |
| 127 | astrocyte development (GO:0014002) | 2.51498970 |
| 128 | hydrogen peroxide catabolic process (GO:0042744) | 2.50611353 |
| 129 | positive regulation of action potential (GO:0045760) | 2.49684675 |
| 130 | sequestering of actin monomers (GO:0042989) | 2.49411200 |
| 131 | cullin deneddylation (GO:0010388) | 2.48945462 |
| 132 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.48210279 |
| 133 | glycolipid biosynthetic process (GO:0009247) | 2.46070646 |
| 134 | * protein targeting to mitochondrion (GO:0006626) | 2.45954123 |
| 135 | UTP biosynthetic process (GO:0006228) | 2.45922103 |
| 136 | positive regulation of protein homodimerization activity (GO:0090073) | 2.45403181 |
| 137 | ribosomal small subunit assembly (GO:0000028) | 2.44505600 |
| 138 | metallo-sulfur cluster assembly (GO:0031163) | 2.44057870 |
| 139 | iron-sulfur cluster assembly (GO:0016226) | 2.44057870 |
| 140 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.44037401 |
| 141 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.43698795 |
| 142 | regulation of cellular respiration (GO:0043457) | 2.41582845 |
| 143 | response to misfolded protein (GO:0051788) | 2.41347457 |
| 144 | protein targeting to membrane (GO:0006612) | 2.41144765 |
| 145 | regulation of cholesterol storage (GO:0010885) | 2.40817483 |
| 146 | protein deneddylation (GO:0000338) | 2.39939363 |
| 147 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.39773777 |
| 148 | aerobic respiration (GO:0009060) | 2.39580944 |
| 149 | aldehyde catabolic process (GO:0046185) | 2.38649364 |
| 150 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.37859766 |
| 151 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.37677141 |
| 152 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.37645596 |
| 153 | creatine metabolic process (GO:0006600) | 2.37265152 |
| 154 | translational initiation (GO:0006413) | 2.36892617 |
| 155 | dopamine transport (GO:0015872) | 2.36695852 |
| 156 | intracellular protein transmembrane import (GO:0044743) | 2.36219341 |
| 157 | base-excision repair, AP site formation (GO:0006285) | 2.35814829 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.92884280 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.14865290 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.87699843 |
| 4 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.26421602 |
| 5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.91945888 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.89760530 |
| 7 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.79427330 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.72046864 |
| 9 | * NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.57268853 |
| 10 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.40415241 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.39681446 |
| 12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.38142495 |
| 13 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.37541338 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.36502734 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.32196274 |
| 16 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.32085886 |
| 17 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.31390361 |
| 18 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.18739313 |
| 19 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.17741331 |
| 20 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 2.05465180 |
| 21 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.02154366 |
| 22 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.98876569 |
| 23 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.98540213 |
| 24 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.97600223 |
| 25 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96480421 |
| 26 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.95821857 |
| 27 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.91594886 |
| 28 | VDR_22108803_ChIP-Seq_LS180_Human | 1.90467588 |
| 29 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.89410390 |
| 30 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.87864096 |
| 31 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.83586235 |
| 32 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.81025211 |
| 33 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.78881637 |
| 34 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.77746500 |
| 35 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.71477075 |
| 36 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.70934502 |
| 37 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.65835963 |
| 38 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.65322836 |
| 39 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.65035145 |
| 40 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.63637696 |
| 41 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.61715548 |
| 42 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.61303631 |
| 43 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.58990674 |
| 44 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.57922831 |
| 45 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.57285153 |
| 46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.56980323 |
| 47 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.56448776 |
| 48 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.56375601 |
| 49 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.55542649 |
| 50 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.54981203 |
| 51 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.53955342 |
| 52 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.52937673 |
| 53 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.50889028 |
| 54 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.50866148 |
| 55 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.50817936 |
| 56 | P68_20966046_ChIP-Seq_HELA_Human | 1.49789819 |
| 57 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.49265211 |
| 58 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48928891 |
| 59 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.47559833 |
| 60 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.46986491 |
| 61 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.45438049 |
| 62 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.45167203 |
| 63 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.43530857 |
| 64 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.42390820 |
| 65 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.40902513 |
| 66 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.40902513 |
| 67 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.40314255 |
| 68 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.38297594 |
| 69 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.36953289 |
| 70 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.36504289 |
| 71 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.36426466 |
| 72 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.32508950 |
| 73 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.32477204 |
| 74 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.32426220 |
| 75 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.31484529 |
| 76 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.31308458 |
| 77 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.30547498 |
| 78 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26211168 |
| 79 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.26182715 |
| 80 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.19306725 |
| 81 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18769963 |
| 82 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.18507414 |
| 83 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.18503890 |
| 84 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.16471680 |
| 85 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.15924540 |
| 86 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.15670171 |
| 87 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.14645333 |
| 88 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.14018058 |
| 89 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.13816027 |
| 90 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.13655920 |
| 91 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.13611253 |
| 92 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.13595383 |
| 93 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.12838531 |
| 94 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.12710719 |
| 95 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.11395484 |
| 96 | SA1_27219007_Chip-Seq_Bcells_Human | 1.10946978 |
| 97 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.10922122 |
| 98 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.10731010 |
| 99 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.09632959 |
| 100 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.09599637 |
| 101 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.09331641 |
| 102 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.08673708 |
| 103 | P300_19829295_ChIP-Seq_ESCs_Human | 1.08418662 |
| 104 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.08410785 |
| 105 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.07108730 |
| 106 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.06281145 |
| 107 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.06020737 |
| 108 | FUS_26573619_Chip-Seq_HEK293_Human | 1.05772967 |
| 109 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.05456104 |
| 110 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.05063818 |
| 111 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.04683352 |
| 112 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.03801571 |
| 113 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.03688229 |
| 114 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.03643437 |
| 115 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.03398066 |
| 116 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.02904499 |
| 117 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.02417754 |
| 118 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.02265488 |
| 119 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.02012264 |
| 120 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.01049164 |
| 121 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.99533674 |
| 122 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.99109798 |
| 123 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.98725267 |
| 124 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.98583238 |
| 125 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97787862 |
| 126 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.97482940 |
| 127 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.97231534 |
| 128 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.96591274 |
| 129 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.96317535 |
| 130 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.96156159 |
| 131 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.95428298 |
| 132 | P300_27268052_Chip-Seq_Bcells_Human | 0.95312569 |
| 133 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.94957873 |
| 134 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.94337742 |
| 135 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.94085415 |
| 136 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94051432 |
| 137 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.93607797 |
| 138 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.93078092 |
| 139 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.92587114 |
| 140 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.92178444 |
| 141 | * SOX2_21211035_ChIP-Seq_LN229_Human | 0.91874709 |
| 142 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91480245 |
| 143 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.91386404 |
| 144 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.91350948 |
| 145 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.91043129 |
| 146 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.90797783 |
| 147 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.89939404 |
| 148 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.89426721 |
| 149 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.89426721 |
| 150 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.88979635 |
| 151 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.88928218 |
| 152 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.88810787 |
| 153 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.87433868 |
| 154 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.87152959 |
| 155 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.86542651 |
| 156 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.83822490 |
| 157 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.83165647 |
| 158 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.81490479 |
| 159 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.81087398 |
| 160 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.80487920 |
| 161 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.79402007 |
| 162 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.77343943 |
| 163 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.77283893 |
| 164 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.77151150 |
| 165 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.76822533 |
| 166 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.75771918 |
| 167 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.75614135 |
| 168 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.74354143 |
| 169 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.73991635 |
| 170 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.73645159 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002653_abnormal_ependyma_morphology | 4.24689142 |
| 2 | MP0003880_abnormal_central_pattern | 4.19328326 |
| 3 | MP0001529_abnormal_vocalization | 3.94840710 |
| 4 | MP0005670_abnormal_white_adipose | 3.78185316 |
| 5 | MP0000920_abnormal_myelination | 3.55892025 |
| 6 | MP0001905_abnormal_dopamine_level | 3.42775935 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 2.78047550 |
| 8 | MP0004270_analgesia | 2.56187220 |
| 9 | MP0004142_abnormal_muscle_tone | 2.53771150 |
| 10 | MP0009379_abnormal_foot_pigmentation | 2.49559586 |
| 11 | MP0002272_abnormal_nervous_system | 2.49539110 |
| 12 | MP0003011_delayed_dark_adaptation | 2.43374857 |
| 13 | MP0002736_abnormal_nociception_after | 2.24573001 |
| 14 | MP0002064_seizures | 2.22048192 |
| 15 | MP0004742_abnormal_vestibular_system | 2.19163644 |
| 16 | MP0001968_abnormal_touch/_nociception | 2.17719696 |
| 17 | MP0006276_abnormal_autonomic_nervous | 2.16645125 |
| 18 | MP0009745_abnormal_behavioral_response | 2.03838398 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 2.02976568 |
| 20 | MP0001486_abnormal_startle_reflex | 1.90703534 |
| 21 | MP0004147_increased_porphyrin_level | 1.87985494 |
| 22 | MP0002735_abnormal_chemical_nociception | 1.84333397 |
| 23 | MP0009840_abnormal_foam_cell | 1.84310116 |
| 24 | MP0005409_darkened_coat_color | 1.82728193 |
| 25 | MP0005171_absent_coat_pigmentation | 1.80739006 |
| 26 | MP0003136_yellow_coat_color | 1.75872529 |
| 27 | MP0003315_abnormal_perineum_morphology | 1.73821060 |
| 28 | MP0003635_abnormal_synaptic_transmissio | 1.73605098 |
| 29 | MP0009046_muscle_twitch | 1.72428100 |
| 30 | MP0001970_abnormal_pain_threshold | 1.71965849 |
| 31 | MP0005423_abnormal_somatic_nervous | 1.70494498 |
| 32 | MP0000750_abnormal_muscle_regeneration | 1.70161479 |
| 33 | MP0001485_abnormal_pinna_reflex | 1.69541780 |
| 34 | MP0001986_abnormal_taste_sensitivity | 1.67602611 |
| 35 | MP0004130_abnormal_muscle_cell | 1.67519764 |
| 36 | MP0002572_abnormal_emotion/affect_behav | 1.67232994 |
| 37 | MP0000751_myopathy | 1.66825924 |
| 38 | MP0003329_amyloid_beta_deposits | 1.65436187 |
| 39 | MP0003950_abnormal_plasma_membrane | 1.59100968 |
| 40 | MP0000516_abnormal_urinary_system | 1.58987026 |
| 41 | MP0005367_renal/urinary_system_phenotyp | 1.58987026 |
| 42 | MP0005451_abnormal_body_composition | 1.58368951 |
| 43 | MP0004859_abnormal_synaptic_plasticity | 1.55490898 |
| 44 | MP0000778_abnormal_nervous_system | 1.54080708 |
| 45 | MP0002733_abnormal_thermal_nociception | 1.53854311 |
| 46 | MP0001440_abnormal_grooming_behavior | 1.53529954 |
| 47 | MP0003634_abnormal_glial_cell | 1.53481621 |
| 48 | MP0002638_abnormal_pupillary_reflex | 1.44625092 |
| 49 | MP0002067_abnormal_sensory_capabilities | 1.44456303 |
| 50 | MP0000747_muscle_weakness | 1.44259789 |
| 51 | MP0001661_extended_life_span | 1.44193131 |
| 52 | MP0008260_abnormal_autophagy | 1.42790294 |
| 53 | MP0005058_abnormal_lysosome_morphology | 1.42671007 |
| 54 | MP0000372_irregular_coat_pigmentation | 1.41909965 |
| 55 | MP0002063_abnormal_learning/memory/cond | 1.38597661 |
| 56 | MP0005645_abnormal_hypothalamus_physiol | 1.38429279 |
| 57 | MP0003879_abnormal_hair_cell | 1.38157646 |
| 58 | MP0002229_neurodegeneration | 1.37444313 |
| 59 | MP0003690_abnormal_glial_cell | 1.36535545 |
| 60 | MP0002822_catalepsy | 1.34715500 |
| 61 | MP0005084_abnormal_gallbladder_morpholo | 1.32287984 |
| 62 | MP0004043_abnormal_pH_regulation | 1.31564808 |
| 63 | MP0005330_cardiomyopathy | 1.28823243 |
| 64 | MP0006036_abnormal_mitochondrial_physio | 1.28689307 |
| 65 | MP0004381_abnormal_hair_follicle | 1.26778406 |
| 66 | MP0005332_abnormal_amino_acid | 1.24836495 |
| 67 | MP0002138_abnormal_hepatobiliary_system | 1.24521674 |
| 68 | MP0001764_abnormal_homeostasis | 1.20220014 |
| 69 | MP0002163_abnormal_gland_morphology | 1.20072526 |
| 70 | MP0000003_abnormal_adipose_tissue | 1.19888719 |
| 71 | MP0004924_abnormal_behavior | 1.19806082 |
| 72 | MP0005386_behavior/neurological_phenoty | 1.19806082 |
| 73 | MP0002938_white_spotting | 1.18077467 |
| 74 | MP0002837_dystrophic_cardiac_calcinosis | 1.17392322 |
| 75 | MP0010386_abnormal_urinary_bladder | 1.16663698 |
| 76 | MP0002971_abnormal_brown_adipose | 1.16351651 |
| 77 | MP0000049_abnormal_middle_ear | 1.15316695 |
| 78 | MP0002148_abnormal_hypersensitivity_rea | 1.13469496 |
| 79 | MP0004885_abnormal_endolymph | 1.13285572 |
| 80 | MP0001963_abnormal_hearing_physiology | 1.12825396 |
| 81 | MP0002160_abnormal_reproductive_system | 1.12729636 |
| 82 | MP0008875_abnormal_xenobiotic_pharmacok | 1.12531896 |
| 83 | MP0005410_abnormal_fertilization | 1.11853535 |
| 84 | MP0003656_abnormal_erythrocyte_physiolo | 1.11734633 |
| 85 | MP0000749_muscle_degeneration | 1.11641755 |
| 86 | MP0002066_abnormal_motor_capabilities/c | 1.11201962 |
| 87 | MP0005551_abnormal_eye_electrophysiolog | 1.11139126 |
| 88 | MP0004185_abnormal_adipocyte_glucose | 1.11133114 |
| 89 | MP0002882_abnormal_neuron_morphology | 1.10480336 |
| 90 | MP0005379_endocrine/exocrine_gland_phen | 1.10202878 |
| 91 | MP0003646_muscle_fatigue | 1.09736891 |
| 92 | MP0003806_abnormal_nucleotide_metabolis | 1.09340497 |
| 93 | MP0001849_ear_inflammation | 1.06402968 |
| 94 | MP0000955_abnormal_spinal_cord | 1.06283236 |
| 95 | MP0004510_myositis | 1.03845709 |
| 96 | MP0004145_abnormal_muscle_electrophysio | 1.01927610 |
| 97 | MP0002102_abnormal_ear_morphology | 1.01416026 |
| 98 | MP0001984_abnormal_olfaction | 1.01137561 |
| 99 | MP0010030_abnormal_orbit_morphology | 1.01127977 |
| 100 | MP0003724_increased_susceptibility_to | 1.00956993 |
| 101 | MP0002752_abnormal_somatic_nervous | 1.00777769 |
| 102 | MP0003186_abnormal_redox_activity | 1.00689294 |
| 103 | MP0004134_abnormal_chest_morphology | 1.00240794 |
| 104 | MP0005365_abnormal_bile_salt | 0.99909607 |
| 105 | MP0001188_hyperpigmentation | 0.99173759 |
| 106 | MP0009384_cardiac_valve_regurgitation | 0.98687356 |
| 107 | MP0003137_abnormal_impulse_conducting | 0.98666842 |
| 108 | MP0002184_abnormal_innervation | 0.97152045 |
| 109 | MP0005408_hypopigmentation | 0.96445572 |
| 110 | MP0008569_lethality_at_weaning | 0.96054941 |
| 111 | MP0005636_abnormal_mineral_homeostasis | 0.94836411 |
| 112 | MP0002972_abnormal_cardiac_muscle | 0.94672027 |
| 113 | MP0001501_abnormal_sleep_pattern | 0.94597537 |
| 114 | MP0003631_nervous_system_phenotype | 0.94406593 |
| 115 | MP0002557_abnormal_social/conspecific_i | 0.94035868 |
| 116 | MP0000026_abnormal_inner_ear | 0.93162407 |
| 117 | MP0002132_abnormal_respiratory_system | 0.91994019 |
| 118 | MP0002876_abnormal_thyroid_physiology | 0.91837886 |
| 119 | MP0001756_abnormal_urination | 0.91480139 |
| 120 | MP0009053_abnormal_anal_canal | 0.91284633 |
| 121 | MP0003122_maternal_imprinting | 0.91224916 |
| 122 | MP0000343_altered_response_to | 0.90693447 |
| 123 | MP0003632_abnormal_nervous_system | 0.90502163 |
| 124 | MP0005620_abnormal_muscle_contractility | 0.89083522 |
| 125 | MP0003638_abnormal_response/metabolism_ | 0.86029371 |
| 126 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.85793889 |
| 127 | MP0005666_abnormal_adipose_tissue | 0.85308952 |
| 128 | MP0004215_abnormal_myocardial_fiber | 0.85264665 |
| 129 | MP0003633_abnormal_nervous_system | 0.85215325 |
| 130 | MP0002295_abnormal_pulmonary_circulatio | 0.83697614 |
| 131 | MP0009780_abnormal_chondrocyte_physiolo | 0.83520882 |
| 132 | MP0005535_abnormal_body_temperature | 0.82025510 |
| 133 | MP0002751_abnormal_autonomic_nervous | 0.81980713 |
| 134 | MP0005646_abnormal_pituitary_gland | 0.81142308 |
| 135 | MP0000759_abnormal_skeletal_muscle | 0.81037360 |
| 136 | MP0005253_abnormal_eye_physiology | 0.81014694 |
| 137 | MP0006072_abnormal_retinal_apoptosis | 0.80910880 |
| 138 | MP0004019_abnormal_vitamin_homeostasis | 0.80057608 |
| 139 | MP0001727_abnormal_embryo_implantation | 0.79827116 |
| 140 | MP0006035_abnormal_mitochondrial_morpho | 0.79461669 |
| 141 | MP0002909_abnormal_adrenal_gland | 0.79343703 |
| 142 | MP0003172_abnormal_lysosome_physiology | 0.78202857 |
| 143 | MP0001664_abnormal_digestion | 0.76913327 |
| 144 | MP0000013_abnormal_adipose_tissue | 0.76269458 |
| 145 | MP0009643_abnormal_urine_homeostasis | 0.74527536 |
| 146 | MP0009785_altered_susceptibility_to | 0.73873301 |
| 147 | MP0005083_abnormal_biliary_tract | 0.73002329 |
| 148 | MP0004087_abnormal_muscle_fiber | 0.72331026 |
| 149 | MP0002106_abnormal_muscle_physiology | 0.72265223 |
| 150 | MP0005375_adipose_tissue_phenotype | 0.71289135 |
| 151 | MP0008872_abnormal_physiological_respon | 0.70637607 |
| 152 | MP0004133_heterotaxia | 0.70034438 |
| 153 | MP0004036_abnormal_muscle_relaxation | 0.69813412 |
| 154 | MP0005075_abnormal_melanosome_morpholog | 0.69655361 |
| 155 | MP0001502_abnormal_circadian_rhythm | 0.69637074 |
| 156 | MP0000604_amyloidosis | 0.64687658 |
| 157 | MP0006082_CNS_inflammation | 0.64655853 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 6.08033346 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.37690327 |
| 3 | Mitochondrial inheritance (HP:0001427) | 5.32983480 |
| 4 | Progressive macrocephaly (HP:0004481) | 5.13203896 |
| 5 | Acute encephalopathy (HP:0006846) | 4.81543180 |
| 6 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.79462810 |
| 7 | Renal Fanconi syndrome (HP:0001994) | 4.56279354 |
| 8 | Hepatocellular necrosis (HP:0001404) | 4.37330201 |
| 9 | Increased hepatocellular lipid droplets (HP:0006565) | 4.32824443 |
| 10 | Increased CSF lactate (HP:0002490) | 4.24312730 |
| 11 | Increased serum pyruvate (HP:0003542) | 4.11058494 |
| 12 | Abnormality of glycolysis (HP:0004366) | 4.11058494 |
| 13 | Leukodystrophy (HP:0002415) | 3.98707074 |
| 14 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.90855807 |
| 15 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.90855807 |
| 16 | Parakeratosis (HP:0001036) | 3.87475800 |
| 17 | 3-Methylglutaconic aciduria (HP:0003535) | 3.80131844 |
| 18 | Lipid accumulation in hepatocytes (HP:0006561) | 3.72040997 |
| 19 | Hepatic necrosis (HP:0002605) | 3.57104591 |
| 20 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.41976333 |
| 21 | Neurofibrillary tangles (HP:0002185) | 3.30815851 |
| 22 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.27448255 |
| 23 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.26808117 |
| 24 | Optic disc pallor (HP:0000543) | 3.22947636 |
| 25 | Cerebral hypomyelination (HP:0006808) | 3.21972113 |
| 26 | Respiratory failure (HP:0002878) | 3.13707372 |
| 27 | Increased intramyocellular lipid droplets (HP:0012240) | 3.13130806 |
| 28 | Sensory axonal neuropathy (HP:0003390) | 3.09019803 |
| 29 | Cerebral edema (HP:0002181) | 3.06845500 |
| 30 | Stenosis of the external auditory canal (HP:0000402) | 3.06732526 |
| 31 | Myokymia (HP:0002411) | 3.00011741 |
| 32 | Oligomenorrhea (HP:0000876) | 2.94219349 |
| 33 | Exertional dyspnea (HP:0002875) | 2.93859911 |
| 34 | Neuroendocrine neoplasm (HP:0100634) | 2.93742044 |
| 35 | Exercise intolerance (HP:0003546) | 2.90621121 |
| 36 | Short 1st metacarpal (HP:0010034) | 2.88405671 |
| 37 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.88405671 |
| 38 | Abnormality of renal resorption (HP:0011038) | 2.86499407 |
| 39 | Pheochromocytoma (HP:0002666) | 2.81932853 |
| 40 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.77607437 |
| 41 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.77607437 |
| 42 | Lactic acidosis (HP:0003128) | 2.68073636 |
| 43 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.67735804 |
| 44 | Reticulocytopenia (HP:0001896) | 2.61281281 |
| 45 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.55938548 |
| 46 | Dicarboxylic aciduria (HP:0003215) | 2.55938548 |
| 47 | Abnormality of the corticospinal tract (HP:0002492) | 2.53870885 |
| 48 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.51153566 |
| 49 | Hypothermia (HP:0002045) | 2.51037322 |
| 50 | Abnormality of the 1st metacarpal (HP:0010009) | 2.50218110 |
| 51 | Increased muscle lipid content (HP:0009058) | 2.50092901 |
| 52 | Peripheral hypomyelination (HP:0007182) | 2.49497364 |
| 53 | Increased serum lactate (HP:0002151) | 2.47049034 |
| 54 | Lethargy (HP:0001254) | 2.41712819 |
| 55 | Retinal dysplasia (HP:0007973) | 2.39638339 |
| 56 | Cerebral hemorrhage (HP:0001342) | 2.31490000 |
| 57 | Generalized aminoaciduria (HP:0002909) | 2.31232717 |
| 58 | Decreased subcutaneous fat (HP:0001002) | 2.29800643 |
| 59 | Abnormal hair whorl (HP:0010721) | 2.29750061 |
| 60 | Limb dystonia (HP:0002451) | 2.25480500 |
| 61 | X-linked dominant inheritance (HP:0001423) | 2.24061484 |
| 62 | Abnormal number of erythroid precursors (HP:0012131) | 2.19940511 |
| 63 | Muscle fiber inclusion bodies (HP:0100299) | 2.17550283 |
| 64 | Short phalanx of the thumb (HP:0009660) | 2.15256272 |
| 65 | Opisthotonus (HP:0002179) | 2.14407446 |
| 66 | Metabolic acidosis (HP:0001942) | 2.12826635 |
| 67 | Myoglobinuria (HP:0002913) | 2.12441170 |
| 68 | Respiratory difficulties (HP:0002880) | 2.12261358 |
| 69 | Nemaline bodies (HP:0003798) | 2.12049336 |
| 70 | Carpal bone hypoplasia (HP:0001498) | 2.11787575 |
| 71 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.07811755 |
| 72 | Cerebral inclusion bodies (HP:0100314) | 2.06162102 |
| 73 | Rhabdomyolysis (HP:0003201) | 2.04968425 |
| 74 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.03964277 |
| 75 | Hypomagnesemia (HP:0002917) | 2.02714238 |
| 76 | Myopathic facies (HP:0002058) | 2.00924489 |
| 77 | Absent thumb (HP:0009777) | 1.98319887 |
| 78 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.97354773 |
| 79 | Abnormality of reticulocytes (HP:0004312) | 1.97278975 |
| 80 | Abnormality of magnesium homeostasis (HP:0004921) | 1.96498777 |
| 81 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.95047485 |
| 82 | Severe muscular hypotonia (HP:0006829) | 1.94038534 |
| 83 | Methylmalonic acidemia (HP:0002912) | 1.91108621 |
| 84 | Supranuclear gaze palsy (HP:0000605) | 1.91071430 |
| 85 | CNS hypomyelination (HP:0003429) | 1.90832450 |
| 86 | Abnormality of urine glucose concentration (HP:0011016) | 1.90802997 |
| 87 | Glycosuria (HP:0003076) | 1.90802997 |
| 88 | Patchy hypopigmentation of hair (HP:0011365) | 1.90195654 |
| 89 | Hepatosplenomegaly (HP:0001433) | 1.88621395 |
| 90 | Focal motor seizures (HP:0011153) | 1.87504081 |
| 91 | Spastic paraparesis (HP:0002313) | 1.86997729 |
| 92 | Medial flaring of the eyebrow (HP:0010747) | 1.86788422 |
| 93 | Hyperphosphaturia (HP:0003109) | 1.86439825 |
| 94 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.85313690 |
| 95 | Autoamputation (HP:0001218) | 1.85087799 |
| 96 | Exercise-induced myalgia (HP:0003738) | 1.84311323 |
| 97 | Vomiting (HP:0002013) | 1.83950512 |
| 98 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.83025153 |
| 99 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.82350022 |
| 100 | Macrocytic anemia (HP:0001972) | 1.81662993 |
| 101 | Distal lower limb muscle weakness (HP:0009053) | 1.81011564 |
| 102 | Abnormality of glycolipid metabolism (HP:0010969) | 1.80061084 |
| 103 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.80061084 |
| 104 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.80061084 |
| 105 | Vaginal atresia (HP:0000148) | 1.79347889 |
| 106 | CNS demyelination (HP:0007305) | 1.79327282 |
| 107 | Ragged-red muscle fibers (HP:0003200) | 1.77768855 |
| 108 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.77620044 |
| 109 | EMG: myopathic abnormalities (HP:0003458) | 1.77508782 |
| 110 | Spastic gait (HP:0002064) | 1.77165525 |
| 111 | Renal tubular dysfunction (HP:0000124) | 1.76576069 |
| 112 | Abnormal pupillary function (HP:0007686) | 1.75649491 |
| 113 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.74714022 |
| 114 | Genital tract atresia (HP:0001827) | 1.74513195 |
| 115 | Stridor (HP:0010307) | 1.73681620 |
| 116 | Emotional lability (HP:0000712) | 1.72846902 |
| 117 | Testicular atrophy (HP:0000029) | 1.72374928 |
| 118 | Poor suck (HP:0002033) | 1.72156084 |
| 119 | Type I transferrin isoform profile (HP:0003642) | 1.72033956 |
| 120 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.71881469 |
| 121 | Calf muscle hypertrophy (HP:0008981) | 1.69723794 |
| 122 | Methylmalonic aciduria (HP:0012120) | 1.69190830 |
| 123 | Esophageal neoplasm (HP:0100751) | 1.68253531 |
| 124 | Neoplasm of head and neck (HP:0012288) | 1.68253531 |
| 125 | Axonal loss (HP:0003447) | 1.67751376 |
| 126 | Reticulocytosis (HP:0001923) | 1.66962093 |
| 127 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.66939265 |
| 128 | Erythroderma (HP:0001019) | 1.66637853 |
| 129 | Oral leukoplakia (HP:0002745) | 1.66585645 |
| 130 | Delusions (HP:0000746) | 1.65082325 |
| 131 | Abnormal ciliary motility (HP:0012262) | 1.64998490 |
| 132 | White forelock (HP:0002211) | 1.64927183 |
| 133 | Abnormal urine phosphate concentration (HP:0012599) | 1.64365923 |
| 134 | Hyperuricemia (HP:0002149) | 1.64007214 |
| 135 | Increased purine levels (HP:0004368) | 1.64007214 |
| 136 | Exercise-induced muscle cramps (HP:0003710) | 1.63319432 |
| 137 | Osteomalacia (HP:0002749) | 1.62012934 |
| 138 | Muscle fiber splitting (HP:0003555) | 1.61919295 |
| 139 | Anxiety (HP:0000739) | 1.61826579 |
| 140 | Gait imbalance (HP:0002141) | 1.61791729 |
| 141 | Amniotic constriction ring (HP:0009775) | 1.60831590 |
| 142 | Abnormality of placental membranes (HP:0011409) | 1.60831590 |
| 143 | Fused cervical vertebrae (HP:0002949) | 1.60550889 |
| 144 | Late onset (HP:0003584) | 1.60250267 |
| 145 | Poor speech (HP:0002465) | 1.59775727 |
| 146 | Esotropia (HP:0000565) | 1.59271133 |
| 147 | Microvesicular hepatic steatosis (HP:0001414) | 1.58558579 |
| 148 | Purpura (HP:0000979) | 1.56327541 |
| 149 | Postnatal microcephaly (HP:0005484) | 1.55889214 |
| 150 | Blindness (HP:0000618) | 1.55609552 |
| 151 | Increased circulating renin level (HP:0000848) | 1.54815274 |
| 152 | Paralysis (HP:0003470) | 1.54116628 |
| 153 | Polyphagia (HP:0002591) | 1.52583613 |
| 154 | Progressive inability to walk (HP:0002505) | 1.52403716 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.01314695 |
| 2 | VRK2 | 4.00631082 |
| 3 | OXSR1 | 3.32764467 |
| 4 | ARAF | 2.92961870 |
| 5 | BCR | 2.67430408 |
| 6 | PBK | 2.57808960 |
| 7 | STK16 | 2.53400544 |
| 8 | CDK19 | 2.47975782 |
| 9 | CASK | 2.44691861 |
| 10 | LIMK1 | 2.41730217 |
| 11 | MAP3K11 | 2.39150695 |
| 12 | MAP3K12 | 2.32475569 |
| 13 | MST4 | 2.09886038 |
| 14 | MAPKAPK5 | 2.06259352 |
| 15 | TNIK | 2.04226058 |
| 16 | CSNK1G3 | 1.84493072 |
| 17 | NME1 | 1.83363378 |
| 18 | UHMK1 | 1.83120950 |
| 19 | WNK4 | 1.78992171 |
| 20 | MUSK | 1.63207909 |
| 21 | PKN1 | 1.60935999 |
| 22 | PINK1 | 1.59639902 |
| 23 | MAPKAPK3 | 1.57966899 |
| 24 | BMPR1B | 1.55295698 |
| 25 | GRK7 | 1.54780624 |
| 26 | MYLK | 1.54364491 |
| 27 | TESK2 | 1.53112179 |
| 28 | PIM2 | 1.49922743 |
| 29 | EPHB1 | 1.48049874 |
| 30 | VRK1 | 1.39319656 |
| 31 | ADRBK2 | 1.37283717 |
| 32 | DYRK2 | 1.36482812 |
| 33 | CAMK2B | 1.33094930 |
| 34 | CSNK1A1L | 1.26756900 |
| 35 | NME2 | 1.26589867 |
| 36 | PAK6 | 1.25448765 |
| 37 | AURKA | 1.24268153 |
| 38 | BUB1 | 1.23148505 |
| 39 | BRAF | 1.22917715 |
| 40 | CSNK1G1 | 1.21591535 |
| 41 | CSNK1G2 | 1.16226107 |
| 42 | GRK5 | 1.15297480 |
| 43 | TAOK1 | 1.10447301 |
| 44 | ROCK2 | 1.09654514 |
| 45 | MAPK13 | 1.08147016 |
| 46 | TRIB3 | 1.06399005 |
| 47 | CLK1 | 1.05402329 |
| 48 | CAMK2D | 0.99832746 |
| 49 | TAOK2 | 0.99502088 |
| 50 | PRKD3 | 0.98592017 |
| 51 | EIF2AK3 | 0.96120943 |
| 52 | MAP2K7 | 0.95107603 |
| 53 | BMPR2 | 0.93746849 |
| 54 | DAPK1 | 0.92995924 |
| 55 | MAP4K2 | 0.92921944 |
| 56 | CAMK2G | 0.92716359 |
| 57 | IRAK4 | 0.91612526 |
| 58 | NEK6 | 0.90183756 |
| 59 | MAP2K3 | 0.87930182 |
| 60 | TLK1 | 0.87404228 |
| 61 | CDK9 | 0.87169143 |
| 62 | PRKD2 | 0.86232108 |
| 63 | PRPF4B | 0.85582934 |
| 64 | OBSCN | 0.85516819 |
| 65 | FGR | 0.84909503 |
| 66 | PRKCI | 0.83843025 |
| 67 | EPHB2 | 0.83261382 |
| 68 | MAPK12 | 0.80329259 |
| 69 | CAMK2A | 0.80000604 |
| 70 | EPHA4 | 0.79108841 |
| 71 | MARK1 | 0.79003585 |
| 72 | NTRK1 | 0.78983083 |
| 73 | DYRK3 | 0.78211761 |
| 74 | MAP2K1 | 0.77661145 |
| 75 | MAP2K6 | 0.77480142 |
| 76 | MAPK15 | 0.77131987 |
| 77 | CDK14 | 0.76767686 |
| 78 | CCNB1 | 0.76165631 |
| 79 | DAPK2 | 0.75947156 |
| 80 | FES | 0.75728043 |
| 81 | ERN1 | 0.75710564 |
| 82 | PRKCE | 0.74978176 |
| 83 | ILK | 0.74277987 |
| 84 | WNK1 | 0.71621758 |
| 85 | IRAK2 | 0.69778430 |
| 86 | SGK223 | 0.69352019 |
| 87 | SGK494 | 0.69352019 |
| 88 | DAPK3 | 0.68067163 |
| 89 | PRKCQ | 0.67845610 |
| 90 | RPS6KA5 | 0.67759631 |
| 91 | CDK18 | 0.67363461 |
| 92 | CAMK1 | 0.65920603 |
| 93 | MAP2K4 | 0.65882393 |
| 94 | PNCK | 0.65879386 |
| 95 | CDK15 | 0.64282939 |
| 96 | CDK11A | 0.63616464 |
| 97 | BLK | 0.62689158 |
| 98 | MET | 0.62196019 |
| 99 | CDK5 | 0.61664648 |
| 100 | ZAK | 0.61650692 |
| 101 | MAP3K3 | 0.60467648 |
| 102 | WNK3 | 0.58781966 |
| 103 | CAMKK1 | 0.58550579 |
| 104 | ADRBK1 | 0.58315818 |
| 105 | PRKD1 | 0.57561204 |
| 106 | PDK2 | 0.54051128 |
| 107 | PLK2 | 0.53806015 |
| 108 | MAP2K2 | 0.53628955 |
| 109 | BRSK1 | 0.53579875 |
| 110 | TBK1 | 0.53507431 |
| 111 | ABL2 | 0.53278409 |
| 112 | LMTK2 | 0.52147270 |
| 113 | TESK1 | 0.51222768 |
| 114 | KDR | 0.48089749 |
| 115 | NTRK3 | 0.47698295 |
| 116 | CAMKK2 | 0.47504847 |
| 117 | PAK1 | 0.46821357 |
| 118 | SYK | 0.46294436 |
| 119 | GRK1 | 0.45456855 |
| 120 | PRKACA | 0.44239623 |
| 121 | TNK2 | 0.43582209 |
| 122 | IRAK3 | 0.43284530 |
| 123 | MINK1 | 0.41023550 |
| 124 | MKNK1 | 0.40297280 |
| 125 | CSNK2A1 | 0.40178742 |
| 126 | EPHA2 | 0.39939618 |
| 127 | PHKG2 | 0.39272526 |
| 128 | PHKG1 | 0.39272526 |
| 129 | TIE1 | 0.38668414 |
| 130 | SIK1 | 0.38204607 |
| 131 | PRKG2 | 0.38109395 |
| 132 | LRRK2 | 0.38042630 |
| 133 | INSRR | 0.37745611 |
| 134 | AKT2 | 0.37721776 |
| 135 | PAK4 | 0.37048449 |
| 136 | DYRK1B | 0.36262669 |
| 137 | MAPK4 | 0.36043289 |
| 138 | CSNK1A1 | 0.35885852 |
| 139 | PRKG1 | 0.34129428 |
| 140 | SIK3 | 0.33789123 |
| 141 | BCKDK | 0.33522808 |
| 142 | PTK2B | 0.32693520 |
| 143 | IKBKB | 0.32018154 |
| 144 | PAK3 | 0.31834078 |
| 145 | RAF1 | 0.30092449 |
| 146 | NTRK2 | 0.29141612 |
| 147 | PRKCD | 0.28758380 |
| 148 | PRKCG | 0.28547338 |
| 149 | FYN | 0.28509788 |
| 150 | TXK | 0.28186010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 5.66292020 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 4.70881468 |
| 3 | Alzheimers disease_Homo sapiens_hsa05010 | 3.67046477 |
| 4 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.57094848 |
| 5 | Protein export_Homo sapiens_hsa03060 | 3.38874148 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 3.22085941 |
| 7 | Huntingtons disease_Homo sapiens_hsa05016 | 3.14673326 |
| 8 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.02228048 |
| 9 | Proteasome_Homo sapiens_hsa03050 | 3.01539446 |
| 10 | Sulfur relay system_Homo sapiens_hsa04122 | 2.90787238 |
| 11 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.83871449 |
| 12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.40577249 |
| 13 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.32302338 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.32094432 |
| 15 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.15942100 |
| 16 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.05583708 |
| 17 | RNA polymerase_Homo sapiens_hsa03020 | 1.93600164 |
| 18 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.88259782 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.77804678 |
| 20 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.77510793 |
| 21 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.71333799 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.60040787 |
| 23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.59944491 |
| 24 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38801151 |
| 25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.34692846 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.26890779 |
| 27 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.23148305 |
| 28 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.17523790 |
| 29 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.13267831 |
| 30 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12400839 |
| 31 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.10736744 |
| 32 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.09944317 |
| 33 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05875978 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.05774439 |
| 35 | Phagosome_Homo sapiens_hsa04145 | 1.05711277 |
| 36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.04794384 |
| 37 | Galactose metabolism_Homo sapiens_hsa00052 | 1.01362759 |
| 38 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.01057860 |
| 39 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99579147 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.98419889 |
| 41 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.98121920 |
| 42 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.97314295 |
| 43 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.96014601 |
| 44 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.95097912 |
| 45 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.93093320 |
| 46 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.93026540 |
| 47 | Histidine metabolism_Homo sapiens_hsa00340 | 0.88748287 |
| 48 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.88582993 |
| 49 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.87852941 |
| 50 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.87360967 |
| 51 | GABAergic synapse_Homo sapiens_hsa04727 | 0.87336927 |
| 52 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.87148282 |
| 53 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.86224786 |
| 54 | Nicotine addiction_Homo sapiens_hsa05033 | 0.85387950 |
| 55 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.82178085 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81489065 |
| 57 | Phototransduction_Homo sapiens_hsa04744 | 0.81403241 |
| 58 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.80881307 |
| 59 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.76967444 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.75526596 |
| 61 | Morphine addiction_Homo sapiens_hsa05032 | 0.74481016 |
| 62 | Metabolic pathways_Homo sapiens_hsa01100 | 0.72637060 |
| 63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.72416097 |
| 64 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.72097487 |
| 65 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.70233311 |
| 66 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.69960845 |
| 67 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.68115767 |
| 68 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.67677656 |
| 69 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.64659553 |
| 70 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.64466109 |
| 71 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.63700181 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.63403807 |
| 73 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.62311402 |
| 74 | Axon guidance_Homo sapiens_hsa04360 | 0.62191829 |
| 75 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.61535686 |
| 76 | Cocaine addiction_Homo sapiens_hsa05030 | 0.61378407 |
| 77 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.60791390 |
| 78 | Basal transcription factors_Homo sapiens_hsa03022 | 0.58195910 |
| 79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.55833705 |
| 80 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.55259335 |
| 81 | Purine metabolism_Homo sapiens_hsa00230 | 0.54534498 |
| 82 | Asthma_Homo sapiens_hsa05310 | 0.53893182 |
| 83 | Long-term depression_Homo sapiens_hsa04730 | 0.53859128 |
| 84 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.53481195 |
| 85 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.52111208 |
| 86 | Taste transduction_Homo sapiens_hsa04742 | 0.51945841 |
| 87 | Circadian entrainment_Homo sapiens_hsa04713 | 0.50878623 |
| 88 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.50428481 |
| 89 | Retinol metabolism_Homo sapiens_hsa00830 | 0.50266039 |
| 90 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.50164382 |
| 91 | Base excision repair_Homo sapiens_hsa03410 | 0.49868793 |
| 92 | Allograft rejection_Homo sapiens_hsa05330 | 0.48500898 |
| 93 | Insulin secretion_Homo sapiens_hsa04911 | 0.45303829 |
| 94 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.45241271 |
| 95 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.44982516 |
| 96 | Mineral absorption_Homo sapiens_hsa04978 | 0.44760510 |
| 97 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.44693212 |
| 98 | Homologous recombination_Homo sapiens_hsa03440 | 0.44454532 |
| 99 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.44253837 |
| 100 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.44083563 |
| 101 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.43447603 |
| 102 | Alcoholism_Homo sapiens_hsa05034 | 0.42656577 |
| 103 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.42473784 |
| 104 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.40848545 |
| 105 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.40395966 |
| 106 | Lysosome_Homo sapiens_hsa04142 | 0.38350484 |
| 107 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.36769984 |
| 108 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.35803251 |
| 109 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.34279288 |
| 110 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.33526638 |
| 111 | Olfactory transduction_Homo sapiens_hsa04740 | 0.32886223 |
| 112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31033464 |
| 113 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.29832836 |
| 114 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.29563491 |
| 115 | Peroxisome_Homo sapiens_hsa04146 | 0.28907011 |
| 116 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.28409286 |
| 117 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.28101862 |
| 118 | DNA replication_Homo sapiens_hsa03030 | 0.27210348 |
| 119 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.27028393 |
| 120 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.26088322 |
| 121 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.25906844 |
| 122 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.24072012 |
| 123 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.23979567 |
| 124 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.23580304 |
| 125 | Pertussis_Homo sapiens_hsa05133 | 0.23029418 |
| 126 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.20456883 |
| 127 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.19786552 |
| 128 | Malaria_Homo sapiens_hsa05144 | 0.19599250 |
| 129 | Salivary secretion_Homo sapiens_hsa04970 | 0.18203148 |
| 130 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.18052659 |
| 131 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.17866478 |
| 132 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.15854393 |
| 133 | Salmonella infection_Homo sapiens_hsa05132 | 0.15493312 |
| 134 | Spliceosome_Homo sapiens_hsa03040 | 0.14216998 |
| 135 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.14194274 |
| 136 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.13794918 |
| 137 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.13505520 |
| 138 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.13118385 |
| 139 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.12294101 |
| 140 | Other glycan degradation_Homo sapiens_hsa00511 | 0.11701266 |
| 141 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.09114270 |
| 142 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.07906095 |
| 143 | Endocytosis_Homo sapiens_hsa04144 | 0.06883793 |
| 144 | Gap junction_Homo sapiens_hsa04540 | 0.06301091 |

